Verona Pharma Plc Company Profile (LON:VRP)

About Verona Pharma Plc (LON:VRP)

Verona Pharma Plc logoVerona Pharma plc is a United Kingdom-based clinical-stage biopharmaceutical company. The principal activity of the Company is the development of drugs for the treatment of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis. The Company's product candidate, RPL554, is a dual inhibitor of the enzymes phosphodiesterase 3 and 4 (PDE3 and PDE4) that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. The Company is developing RPL554 in a nebulized formulation for the maintenance treatment of COPD patients and for the treatment of cystic fibrosis. It also is developing RPL554 as an add-on therapy to commonly used therapies for the treatment of acute exacerbations of COPD in the hospital setting. In addition to its nebulized formulation of RPL554, the Company is developing RPL554 in both dry powder inhaler (DPI) and metered dose inhaler (MDI) formulations for the maintenance treatment of COPD.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:VRP
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: £78.33 million
  • Outstanding Shares: 51,361,000
Average Prices:
  • 50 Day Moving Avg: GBX 135.69
  • 200 Day Moving Avg: GBX 151.59
  • 52 Week Range: GBX 120.77 - GBX 210
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: GBX 0.67 per share
  • Price / Book: 2.28
Profitability:
  • EBIDTA: ($6,960,000.00)
Misc:
  • Average Volume: 24,690 shs.
 

Frequently Asked Questions for Verona Pharma Plc (LON:VRP)

What is Verona Pharma Plc's stock symbol?

Verona Pharma Plc trades on the London Stock Exchange (LON) under the ticker symbol "VRP."

Where is Verona Pharma Plc's stock going? Where will Verona Pharma Plc's stock price be in 2017?

4 brokerages have issued 12 month price targets for Verona Pharma Plc's shares. Their forecasts range from GBX 22 to GBX 250. On average, they expect Verona Pharma Plc's share price to reach GBX 80.75 in the next year. View Analyst Ratings for Verona Pharma Plc.

Who are some of Verona Pharma Plc's key competitors?

How do I buy Verona Pharma Plc stock?

Shares of Verona Pharma Plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Verona Pharma Plc stock cost?

One share of Verona Pharma Plc stock can currently be purchased for approximately GBX 152.50.

Analyst Ratings

Consensus Ratings for Verona Pharma Plc (LON:VRP) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 80.75

Analysts' Ratings History for Verona Pharma Plc (LON:VRP)
Show:
DateFirmActionRatingPrice TargetDetails
5/22/2017WedbushInitiated CoverageOutperformGBX 25View Rating Details
5/22/2017SunTrust Banks, Inc.Initiated CoverageBuyGBX 26View Rating Details
5/22/2017Stifel NicolausInitiated CoverageBuyGBX 22View Rating Details
5/22/2017Jefferies Group LLCInitiated CoverageBuyGBX 250View Rating Details
4/19/2017N+1 SingerReiterated RatingCorporateView Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for Verona Pharma Plc (LON:VRP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Verona Pharma Plc (LON:VRP)
Current Year EPS Consensus Estimate: $-38.15 EPS

Dividends

Dividend History for Verona Pharma Plc (LON:VRP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Verona Pharma Plc (LON:VRP)
Insider Trades by Quarter for Verona Pharma Plc (LON:VRP)
Insider Trades by Quarter for Verona Pharma Plc (LON:VRP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/27/2017David EbsworthInsiderBuy177,776GBX 169£300,441.44
4/26/2017David EbsworthInsiderBuy13,373GBX 132£17,652.36
3/1/2017Sven Jan-Anders KarlssonInsiderBuy7,750GBX 149£11,547.50
2/28/2017Sven Jan-Anders KarlssonInsiderBuy12,000GBX 149£17,880
8/9/2016Jan-Anders Karlsson,SvenInsiderBuy600,000GBX 3£18,000
1/20/2016Ebsworth,DavidInsiderBuy400,000GBX 3£12,000
12/3/2015Ebsworth,DavidInsiderBuy370,000GBX 3£11,100
6/17/2015David EbsworthInsiderBuy250,000GBX 4.70£11,750
5/18/2015David EbsworthInsiderBuy300,000GBX 3.50£10,500
3/3/2015David EbsworthInsiderBuy450,000GBX 2.43£10,935
2/16/2015Biresh RoyInsiderBuy500,000GBX 2.30£11,500
2/13/2015Sven Jan-Anders KarlssonInsiderBuy1,025,909GBX 2£20,518.18
2/4/2015David EbsworthInsiderBuy700,000GBX 1.54£10,780
1/19/2015Stuart BottomlyInsiderBuy1,000,000GBX 1.50£15,000
1/13/2015David EbsworthInsiderBuy803,107GBX 1.35£10,841.94
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Verona Pharma Plc (LON:VRP)
Latest Headlines for Verona Pharma Plc (LON:VRP)
Source:
DateHeadline
finance.yahoo.com logoVerona Pharma Announces Further Exercise of Over-Allotment Option and Resulting Total Voting Rights
finance.yahoo.com - May 25 at 6:59 AM
finance.yahoo.com logoVerona Pharma to Present at Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - May 23 at 7:58 PM
americanbankingnews.com logoJefferies Group LLC Initiates Coverage on Verona Pharma Plc (VRP)
www.americanbankingnews.com - May 22 at 9:34 PM
americanbankingnews.com logoVerona Pharma Plc (VRP) Earns Buy Rating from Analysts at SunTrust Banks, Inc.
www.americanbankingnews.com - May 22 at 2:00 PM
americanbankingnews.com logoVerona Pharma Plc (VRP) Now Covered by Wedbush
www.americanbankingnews.com - May 22 at 1:24 PM
americanbankingnews.com logoVerona Pharma Plc (VRP) Earns Buy Rating from Analysts at Stifel Nicolaus
www.americanbankingnews.com - May 22 at 9:04 AM
globenewswire.com logoVerona Pharma Announces Closing of Exercise of Underwriters' Over-allotment Option - GlobeNewswire (press release)
globenewswire.com - May 19 at 1:40 PM
finance.yahoo.com logoVerona Pharma Announces Closing of Exercise of Underwriters’ Over-allotment Option
finance.yahoo.com - May 19 at 1:40 PM
businesswire.com logoCiti Appointed Depositary Bank for Verona Pharma’s ADR Programme
www.businesswire.com - May 3 at 6:52 PM
finance.yahoo.com logoGrant of Options and RSUs and PDMR Dealings
finance.yahoo.com - May 3 at 6:52 PM
finance.yahoo.com logoVerona Pharma Announces Closing of Global Offering
finance.yahoo.com - May 2 at 6:38 PM
americanbankingnews.com logoVerona Pharma Plc (VRP) Insider Buys £17,652.36 in Stock
www.americanbankingnews.com - May 1 at 7:12 AM
americanbankingnews.com logoVerona Pharma Plc (VRP) Insider Purchases £300,441.44 in Stock
www.americanbankingnews.com - May 1 at 7:11 AM
globenewswire.com logoVerona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market - GlobeNewswire (press release)
globenewswire.com - April 28 at 10:35 AM
finance.yahoo.com logoVerona Pharma Announces Pricing of Global Offering and Approval to List on the NASDAQ Global Market
finance.yahoo.com - April 27 at 11:48 AM
finance.yahoo.com logoVerona Pharma, Cloudera And 6 Others To Launch IPOs This Week
finance.yahoo.com - April 27 at 11:48 AM
finance.yahoo.com logo[$$] Investor appetite for high-growth IPOs to be tested
finance.yahoo.com - April 25 at 7:30 PM
americanbankingnews.com logoVerona Pharma Plc (VRP) Given  Corporate Rating at N+1 Singer
www.americanbankingnews.com - April 19 at 11:24 AM
americanbankingnews.com logoVerona Pharma Plc (VRP) Receives "corporate" Rating from N+1 Singer
www.americanbankingnews.com - April 8 at 7:58 PM
lse.co.uk logoVerona Pharma Share Chat
www.lse.co.uk - April 1 at 9:48 AM
americanbankingnews.com logoVerona Pharma Plc (VRP) Receives Corporate Rating from N+1 Singer
www.americanbankingnews.com - March 22 at 2:52 PM
uk.finance.yahoo.com logo2 hot growth stocks to buy today on impressive results?
uk.finance.yahoo.com - February 27 at 8:23 AM
lse.co.uk logoResult of General Meeting and Share Consolidation - London South East (registration) (blog)
www.lse.co.uk - February 10 at 6:30 AM
lse.co.uk logoPublication of Circular - London South East (registration) (blog)
www.lse.co.uk - January 18 at 3:45 PM
biz.yahoo.com logoHalf Year 2016 Verona Pharma PLC Earnings Release - Time Not Supplied
biz.yahoo.com - September 13 at 7:20 AM
biz.yahoo.com logoHalf Year 2016 Verona Pharma PLC Earnings Release - Before Market Open
biz.yahoo.com - August 10 at 11:25 AM
finanznachrichten.de logoVERONA PHARMA PLC - Grant of Share Options
www.finanznachrichten.de - August 4 at 11:27 AM
finanznachrichten.de logoVERONA PHARMA PLC - Notice of GM
www.finanznachrichten.de - July 2 at 10:43 AM

Social

Social activity is not available for this stock.

Chart

Verona Pharma Plc (VRP) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff